Trial intelligence / Profile preview

LIA in Hip Arthroscopy Patients

NCT03070054Phase 1Completed

Sponsor
University of Utah
Start
Jun 2016
Primary completion
Mar 2020
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 1, randomised, triple-blind trial of bupivacaine and epinephrine in postoperative pain, sponsored by University of Utah. Primary endpoint: PACU pain scores at 1 day. Started Jun 2016; status: completed.

02

Drugs

bupivacaineepinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03070054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03070054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call